Search for: "TEVA PHARMACEUTICAL INDUSTRIES LTD" Results 121 - 140 of 259
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Nov 2011, 9:55 am by Aaron Barkoff
  Subsequently, LEO Pharma sought to amend its complaint to, among other things, add Teva Pharmaceutical Industries Ltd. as a defendant. [read post]
1 Nov 2011, 6:30 am by Lawrence B. Ebert
The US Supreme Court denied cert in the Temodar case thus allowing Merck & Co. to block Teva Pharmaceutical Industries Ltd. from selling a generic form of the brain-cancer drug Temodar until 2013. [read post]
31 Oct 2011, 5:46 pm
Barr Laboratories, a division of Teva Pharmaceutical Industries, Ltd., filed an ANDA to manufacture a generic version of the brain cancer drug Temodar which is currently covered under a patent owned by Cancer Research Technology and licensed to Merck & Co. [read post]
11 Oct 2011, 8:44 am
It is third verdict for Teva Pharmaceutical Industries Ltd. and Baxter International Inc. over a hepatitis outbreak related to Propofol. [read post]
10 Oct 2011, 10:00 am by Lucas A. Ferrara, Esq.
FTC Requires Sale of Generic Cancer Pain Drug and Muscle Relaxant as Conditions of Teva's $6.8 Billion Acquisition of Cephalon Par Pharmaceuticals Will Acquire Drug Assets, Enter Agreement To Make Generic Provigil To protect competition in the market for prescription drugs, the Federal Trade Commission will require Teva Pharmaceutical Industries Ltd. to sell the rights and assets related to a generic cancer pain drug and a generic muscle… [read post]
20 Sep 2011, 6:35 am by Bexis
Teva Pharmaceutical Industries Ltd., 2011 WL 4062219 (E.D. [read post]
16 Sep 2011, 8:17 am by Bexis
Sun Pharmaceuticals Industries, Ltd, ___ F. [read post]
30 Aug 2011, 5:18 am by Lawrence B. Ebert
The Mylan case is Teva Pharmaceuticals Industries Ltd. v. [read post]
15 Aug 2011, 9:55 am by Patrick G. Lee
Teva Pharmaceutical Industries Ltd., which has proposed a generic version of Viagra, argued that the patent was invalid because anyone well-versed in the art of drug making could have gleaned, from prior research, that sildenafil could be effective as an ED treatment. [read post]
15 Aug 2011, 7:32 am by Phil
(PFE) won a patent- infringement case that prevents Teva Pharmaceutical Industries Ltd. [read post]
27 Jul 2011, 4:06 pm by Lawrence B. Ebert
Caraco :Defendants-Appellees Caraco Pharmaceutical Labora- tories, Ltd. and Sun Pharmaceutical Industries, Ltd. [read post]
2 Jun 2011, 12:46 pm by Bexis
Ortho Pharmaceutical Corp., 681 P.2d 1038, 1052 (Kan. 1984). [read post]
23 May 2011, 9:59 pm by Patent Docs
• Defendants: Impax Laboratories, Inc.; Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries Ltd. [read post]
3 May 2011, 6:00 am
by Andrew Nason In a move approved unanimously by the boards of both companies, Teva Pharmaceutical Industries Ltd., the world's largest generic drug maker, agreed to buy Cephalon Inc. for $81.50 per share in cash, or a total enterprise value of $6.8 billion. [read post]
24 Feb 2011, 2:40 am by sally
Ineos Healthcare Ltd v Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM) (Teva Pharmaceutical Industries Ltd, other party) (Case T-222/09); [2011] WLR (D) 53 “In opposition proceedings against registration of a trade mark pursuant to article 42 of Council Regulation (EC) No 40/94, the opposing party was not obliged to adduce evidence in support of the opposition. [read post]
14 Dec 2010, 6:12 pm
One products liability lawsuit was originally filed by Gladys Mensing, who is suing Teva Pharmaceutical Industries Ltd., Mylan Inc., and Actavis Group. [read post]
17 Nov 2010, 1:48 am by Kelly
(Patently-O) US: Amicus brief filed by Alnylam Pharmaceuticals argues that Funk Bros. is about obviousness, not patent eligibility: AMP v USPTO (Holman’s Biotech IP Blog) US: Amicus briefs in AMP v USPTO: Genetic Alliance (Patent Docs) US: Patent expirations will stabilise the pharmaceutical industry (BiotechBlog) US: Generic industry headed for a ‘180-day exclusivity cliff’ (FDA Law Blog) US: PTO clarifies PTE availability in post-PhotoCure and… [read post]
3 Nov 2010, 7:00 am
Teva Pharmaceutical Industries Ltd. followed the same year. [read post]
31 Oct 2010, 7:00 am
Donahue On November 1, Gary Buehler, the longtime director of FDA's Office of Generic Drugs (OGD), is joining Teva Pharmaceutical Industries Ltd. as Vice President of Regulatory Strategic Operations. [read post]